N. Kasap Et Al. , "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.," Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7, pp.907-910, 2022
Kasap, N. Et Al. 2022. A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7 , 907-910.
Kasap, N., Aslan, K., Karakurt, L. T., Bozkurt, H., Canatan, H., Cavkaytar, O., ... Eken, A.(2022). A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7, 907-910.
Kasap, Nurhan Et Al. "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.," Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7, 907-910, 2022
Kasap, Nurhan Et Al. "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7, pp.907-910, 2022
Kasap, N. Et Al. (2022) . "A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.." Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , vol.52, no.7, pp.907-910.
@article{article, author={Nurhan Kasap Et Al. }, title={A novel gain-of-function mutation in STAT5B is associated with treatment-resistant severe atopic dermatitis.}, journal={Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology}, year=2022, pages={907-910} }